SOUTH SAN FRANCISCO, CA--(Marketwire - March 31, 2008) - Cytokinetics, Incorporated (NASDAQ: CYTK) announced today that an abstract related to non-clinical data for CK-1827452, a novel small molecule activator of cardiac myosin, was presented at the 2008 Annual Scientific Sessions of the American College of Cardiology (ACC) Meeting in Chicago, IL. CK-1827452 is being evaluated in clinical trials for the potential treatment of heart failure and is the subject of a collaboration and option agreement between Cytokinetics and Amgen Inc.
